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Prohibitins form large protein and lipid scaffolds in
the inner membrane of mitochondria that are
required for mitochondrial morphogenesis, neuronal
survival, and normal lifespan. Here, we have defined
the interactome of PHB2 in mitochondria and identi-
fied DNAJC19, mutated in dilated cardiomyopathy
with ataxia, as binding partner of PHB complexes.
We observed impaired cell growth, defective
cristae morphogenesis, and similar transcriptional
responses in the absence of either DNAJC19 or
PHB2. The loss of PHB/DNAJC19 complexes affects
cardiolipin acylation and leads to the accumulation of
cardiolipin species with altered acyl chains. Similar
defects occur in cells lacking the transacylase tafaz-
zin, which is mutated in Barth syndrome. Our exper-
iments suggest that PHB/DNAJC19 membrane
domains regulate cardiolipin remodeling by tafazzin
and explain similar clinical symptoms in two inherited
cardiomyopathies by an impaired cardiolipin meta-
bolism in mitochondrial membranes.
INTRODUCTION
The function of cell organelles depends on a defined lipid
composition of their membranes and a characteristic comple-
ment of embedded proteins. The diphosphoglycerolipid
cardiolipin (CL) is the hallmark phospholipid of mitochondrial
membranes (Osman et al., 2011). It is involved in the biogenesis
of mitochondria and modulates the dynamic behavior of mito-
chondrial membranes and their supramolecular organization.
The stability of several multiprotein complexes in bothmitochon-
drial membranes depends on CL (Kutik et al., 2008; Pfeiffer et al.,
2003; Tamura et al., 2006). Moreover, CL forms specific protein
docking sites, modulating the fusion and fission of mitochondrial
membranes as well as mitophagy and apoptosis (Osman et al.,
2011). Mutations in the CL acyltransferase tafazzin (TAZ) cause
cardiomyopathy in Barth syndrome (BTHS), revealing the patho-158 Cell Metabolism 20, 158–171, July 1, 2014 ª2014 Elsevier Inc.genic relevance of disturbances in CL metabolism (Barth et al.,
1983; Bione et al., 1996; Vreken et al., 2000).
CL is synthesized along an enzymatic cascade in the inner
mitochondrial membrane (IMM) from phosphatidic acid (PA),
which is derived from the endoplasmic reticulum (ER). After the
formation of CL at thematrix side of the IMM, structurally uniform
and symmetric CL molecules are generated by TAZ-mediated
remodeling of their acyl chains (Osman et al., 2011; Schlame
and Haldar, 1993). Remodeling involves the formation of mono-
lyso-CL (MLCL) and subsequent acylation by TAZ (Schlame,
2013). Loss of TAZ in BTHS leads to the accumulation of
MLCL, reduced CL levels, and an altered acyl chain composition
of CL and other phospholipids (Gu et al., 2004; Houtkooper et al.,
2009; Schlame et al., 2003). This is accompanied by a severe
functional and structural impairment of mitochondria (Acehan
et al., 2007).
BTHS patients display dilated cardiomyopathy, skeletal
muscle weakness, neutropenia, growth failure, hypocholestero-
lemia, and 3-methyl glucaconic aciduria (Barth et al., 1983; Kel-
ley et al., 1991). Similar clinical presentations are observed in an
emerging group of inherited human diseases, which includes
dilated cardiomyopathy with ataxia (DCMA), MEGDEL, and
Sengers syndrome. The latter two are caused by mutations in
genes encoding phospholipid synthesizing enzymes in the ER
or mitochondria, suggesting a pathogenic role of a disturbed
membrane lipid homeostasis as in BTHS (Lamari et al., 2013;
Mayr et al., 2012; Wortmann et al., 2012). DCMA, on the other
hand, is associated with mutations in Dnajc19 (Davey et al.,
2006; Ojala et al., 2012). DNAJC19 is homologous to yeast
Pam18/Tim14 (yPam18), a component of the mitochondrial pro-
tein import machinery in the IMM. This raises the possibility that
loss of DNAJC19 in DCMA leads to defects in the import of
nuclear-encoded mitochondrial proteins (Davey et al., 2006).
However, experimental evidence is lacking to show such a func-
tion for DNAJC19, and therefore, the pathogenic mechanism of
DCMA is still elusive.
Increasing evidence suggests that the functional integrity of
mitochondrial membranes also requires a defined spatial organi-
zation of CL and other phospholipids. Proteins of the stomatin/
prohibitin/flotillin/HflK/C (SPFH) family are thought to function
as scaffolds in the IMM that affect the lateral distribution of
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Figure 1. Identification of PHB2 Interactors
(A) Schematic representation of Cre-mediated
Phb2 deletion and expression of CNAP-PHB2 in
Phb2fl/fl::CNAP-Phb2 cells. Cre-mediated re-
combination results in the deletion of the endog-
enous Phb2 and the loxP-flanked STOP-cassette,
leading to the expression of CNAP-tagged
PHB2 (Phb2/::CNAP-Phb2). NeoR: neomycin
resistance.
(B) CNAP-PHB2 complements defects associated
with loss of PHB2. Mitochondria isolated from the
indicated cell lines were subjected to SDS-PAGE
and immunoblotting using antibodies as indicated.
(C) CNAP-PHB2 expression maintains a tubular
mitochondrial network in PHB2-deficient cells.
Indicated MEFs were immunostained using anti-
bodies against cytochrome c and DAPI to visu-
alize mitochondria and the nucleus, respectively.
Scale bar: 10 mm.
(D) PHB2-interacting proteins. Mitochondria
isolated from Phb2/::CNAP-Phb2 MEFs and,
for control, from untreated Phb2fl/fl::CNAP-Phb2
MEFs were subjected to metal affinity purification.
Input (5%), unbound (5%), and eluate (100%)
fractions were analyzed by immunoblotting using
the indicated antibodies.
(E) The CNAP-PHB2 interactome identified by
quantitative, label-free MS. Results from three in-
dependent experiments are presented by p values
(y axis) and fold changes (x axis) on a log scale.
Proteins with a fold change R 2 and a p value%
0.05were considered for further analysis. Reddots
represent proteins of the SPFH family, of the
mitochondrial protein import machinery, as well as
mitochondrial proteases.
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CL Remodeling Requires the PHB/DNAJC19 Complexbothmembrane lipids and proteins and thereby define functional
membrane domains (Christie et al., 2011; Osman et al., 2009).
Prohibitins form large, hetero-oligomeric ring complexes
composed of multiple PHB1 and PHB2 subunits (Tatsuta et al.,
2005). In yeast, the PHB complex interacts with them-AAA pro-
tease, a quality control enzyme with important regulatory func-
tions in the IMM (Steglich et al., 1999). Genetic interaction data
link the function of PHB complexes to mitochondrial CL and
phosphatidyl ethanolamine (PE) and suggest that PHB com-
plexes cluster these phospholipids to ensure their accumulation
at distinct sites in the IMM (Osman et al., 2009). Membrane do-
mains defined by PHB complexes are essential for mitochondrial
integrity and normal lifespan (Artal-Sanz and Tavernarakis,
2009). Loss of PHB complexes in mice leads to embryonic
lethality and, postnatally, to the degeneration of adult neurons
(Merkwirth et al., 2012) and to the loss of b cells and diabetes
(Supale et al., 2013). At the cellular level, depletion of PHB com-
plexes causes proliferation defects, destabilization of the mito-
chondrial genome, disturbances in mitochondrial morphology
and ultrastructure, and an increased sensitivity toward apoptosis
(Kasashima et al., 2008; Merkwirth et al., 2008). Many of these
defects are caused by the loss of long forms of the dynamin-
like GTPase OPA1 (L-OPA1) (Merkwirth et al., 2008), a central
component of the mitochondrial fusion machinery.
Here, we have determined the interactome of PHB2 in the IMM
to obtain comprehensive insight into the function of PHB com-
plexes as scaffold proteins. We identified DNAJC19 as an inter-acting protein that functions in a complex with prohibitins. Loss
of DNAJC19 or PHB complexes impairs CL metabolism and
leads to an altered acyl chain composition of CL as found in
TAZ-deficient cells. Our findings thus indicate that DNAJC19
functions in CL remodeling and reveal striking similarities in the
molecular pathogenesis of two related cardiomyopathies,
DCMA and BTHS.
RESULTS
Determination of the PHB2 Interactome
We established a mouse embryonic fibroblast (MEF) Phb2fl/fl cell
line allowing Cre-recombinase-inducible expression of a PHB2
variant harboring an N-terminal CNAP epitope (for consecutive
nondenaturing affinity purification) (Claypool et al., 2008). A
loxP-flanked STOP-cassette followed by the cDNA encoding
CNAP-Phb2 was inserted into Phb2fl/fl cells (Merkwirth et al.,
2008) (Figure 1A). Cre-mediated recombination resulted in simul-
taneous ablation of endogenous Phb2 and ectopic expression of
CNAP-PHB2, ensuring modification of all PHB2 subunits. PHB2
quantitatively assembles with PHB1 (Coates et al., 2001), which
is degraded in Phb2/ cells (Figure 1B) (Merkwirth et al., 2008).
Expression of CNAP-PHB2 significantly stabilized PHB1 in
Phb2/ cells, indicating assembly of both proteins (Figure 1B).
To assess the functionality of CNAP-PHB2, we monitored the
morphology of mitochondria in these cells. Loss of PHB2 leads
to the degradation of L-OPA1 and to fragmentation of theCell Metabolism 20, 158–171, July 1, 2014 ª2014 Elsevier Inc. 159
Table 1. Determination of the PHB2 Interactome by MS
Name Accession PC PQ p value Max. fold change
SPFH family
PHB2 O35129 38 33 0.0011 41.64
PHB1 P67778 32 30 0.0004 55.60
SLP2 Q99JB2 13 13 0.0132 6.99
Proteases
AFG3L2 Q8JZQ2 42 32 0.0054 11.13
AFG3L1 Q920A7 31 25 0.0011 8.00
SPG7 Q3ULF4 27 26 0.0062 7.87
YME1L1 O88967 18 18 0.0408 2.24
Mitochondrial protein translocase
DNAJC19 Q9CQV7 9 5 0.0023 26.81
PAM16 Q9CQV1 7 7 0.0047 9.25
TIMM50 Q9D880 4 4 0.0263 3.87
TIMM23 Q9WTQ8 3 3 0.0061 6.96
TIMM22 Q9CQ85 2 2 0.0116 5.59
OXPHOS
NDUFS13 Q9ERS2 7 5 0.0119 7.34
NDUFS3 Q9DCT2 2 2 0.0152 5.86
NDUFA5 Q9CPP6 2 2 0.0220 5.60
NDUFA3 Q9CQ91 2 2 0.0161 24.19
NDUFC2 Q9CQ54 2 2 0.0060 4.45
UQCRC2 Q9DB77 2 2 0.0048 6.55
COX4I1 P19783 4 4 0.0034 7.14
COX6C Q9CPQ1 3 3 0.0065 11.37
COX6B1 P56391 2 2 0.0059 12.96
ATP5B P56480 17 16 0.0193 2.45
Others
OCIAD1 Q9CRD0 13 12 0.0097 11.95
C2ORF47 Q8BHE8 7 6 0.0381 6.00
MTCH2 Q791V5 6 6 0.0017 7.07
SLC25A24 Q8BMD8 6 6 0.0089 6.05
C1QBQ O35658 5 5 0.0130 4.23
ATAD1 Q9D5T0 5 5 0.0297 3.60
PTRH2 Q8R2Y8 3 3 0.0012 7.41
TMEM126A Q9D8Y1 3 3 0.0017 12.88
GHITM Q91VC9 3 3 0.0482 3.63
EXOG Q8C163 2 2 0.0011 6.71
Mitochondria isolated from Phb2/::CNAP-Phb2 MEFs were subjected
to metal affinity purification. Eluate fractions of three independent exper-
iments were analyzed by quantitative, label-free MS. PC (peptide count),
number of identified peptides; PQ, peptides used for quantificationR 2.
Fold changeR 2.
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CL Remodeling Requires the PHB/DNAJC19 Complexmitochondrial network (Figures 1B and 1C) (Merkwirth et al.,
2008). Expression of CNAP-PHB2 in Phb2/ cells stabilized
L-OPA1 and restored a tubular, interconnected mitochondrial
network, demonstrating functional complementation by CNAP-
PHB2 (Figures 1B and 1C).
To define the PHB2 interactome, we isolated mitochondria
from Phb2/ cells expressing CNAP-PHB2 and purified
prohibitin complexes by metal affinity chromatography (Fig-160 Cell Metabolism 20, 158–171, July 1, 2014 ª2014 Elsevier Inc.ure 1D). Untreated Phb2fl/fl::CNAP-Phb2 cells, expressing
endogenous PHB2 only, served as control. Elution fractions
were analyzed by quantitative, label-free mass spectrometry
(MS) (Figure 1E; Table 1). The interaction of selected binding
partners with CNAP-PHB2 was verified by SDS-PAGE and
immunoblotting (Figure 1D). PHB1 was highly enriched with
CNAP-PHB2. Other known or expected interaction partners,
including the scaffold protein SLP2 (Da Cruz et al., 2008) or all
subunits of the m-AAA protease (AFG3L1, AFG3L2, and para-
plegin/SPG7), were also copurified. Although with low effi-
ciency, we also found the i-AAA protease YME1L to interact
with CNAP-PHB2. The majority of other enriched proteins
belong to two functional categories: subunits of OXPHOS and
of the ATP synthase complexes, and subunits of the TIM22
and TIM23 translocases, which mediate the import of nuclear-
encoded mitochondrial preproteins into the matrix and IMM.
These findings suggest broad functions of prohibitin complexes
for IMM homeostasis. The enrichment of a large number of IMM
proteins with prohibitins is consistent with their proposed func-
tion as membrane scaffolds.
DNAJC19: An Interactor of the PHB Complex
Among the most enriched proteins with CNAP-PHB2 was
DNAJC19 (Figures 1D and 1E; Table 1). DNAJC19 is homologous
to yPam18 and contains a conserved J-domain, which mediates
the functional interaction with HSP70 chaperones by stimulating
ATPase activity. However, despite high conservation within the
J-domain (61% sequence identity), sequence similarities outside
this domain are limited (Figure 2A). To determine the submito-
chondrial localization of DNAJC19, we isolated mitochondria
from HEK293T cells and examined the resistance of DNAJC19
against externally added protease. DNAJC19 remained pro-
tected against proteinase K in intact mitochondria and upon
osmotic disruption of the outer mitochondrial membrane
(OMM) (Figure 2B). This is in contrast to TIM23 or PHB2, IMM
proteins that expose domains to the intermembrane space
(IMS), and to the soluble IMS protein Smac/DIABLO, but similar
to mitochondrial HSP70 (HSPA9/mortalin) located in the matrix
(Figure 2B). Proteinase K treatment upon disruption of mitochon-
drial membranes by sonication led to efficient degradation of
DNAJC19 and HSPA9 (Figure 2B). In agreement with the pres-
ence of a predicted transmembrane domain (Figure 2A),
DNAJC19 was recovered predominantly in the pellet fraction
upon sodium carbonate extraction of mitochondrial membranes
andwas only released into the supernatant at high pH (Figure 2C)
(Sinha et al., 2010). We therefore conclude that DNAJC19 is
strongly associated with the IMM, exposing its C-terminal
J-domain to the matrix space (Figure 2D).
DNAJC19 and PAM16 Assemble into Different
Complexes
yPam18 assembles with yeast Pam16/Tim16 (yPam16) and en-
sures protein import via TIM23 translocases into mitochondria
(Frazier et al., 2004; Kozany et al., 2004; Li et al., 2004). Although
less enriched than DNAJC19, various subunits of the TIM23
translocase and the mitochondrial import machinery including
mammalian PAM16 were precipitated with CNAP-PHB2 (Fig-
ure 1E; Table 1), raising the possibility that DNAJC19 is required
for protein import. However, we did not observe any deficiencies
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Figure 2. Submitochondrial Localization and Membrane Topology of DNAJC19
(A) ClustalW2 alignment of mouse and human DNAJC19 (DJC19) and of human DNAJC15 (DJC15) and yeast Pam18. Sequence identities are marked by an
asterisk (*), high levels of similarity by a colon (:), and low levels of similarity by a full stop (.). The conserved J-domain containing the HPDmotif (box) is depicted in
bold, and the predicted transmembrane domain in italics, underlined.
(B) Human DNAJC19 localizes to the IMM. Mitochondria isolated from HEK293T cells were subjected to hypotonic swelling or sonication, treated with 50 mg/ml
proteinase K where indicated, and analyzed by immunoblotting.
(C) DNAJC19 is a transmembrane protein. Mitochondria were resuspended in sodium carbonate and loaded on a sucrose cushion followed by centrifugation.
Samples (T, total; P, pellet; S, supernatant) were analyzed by immunoblotting using the indicated antibodies.
(D) Schematic representation of the topology of human DNAJC19 and yeast Pam18. IMS, intermembrane space; IMM, inner mitochondrial membrane.
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or PHB2-deficient cells in vitro (Figure S1A). Consistently,
DNAJC19 lacks an N-terminal domain present in yPam18 (Fig-
ures 2A and 2D), which mediates the interaction with the yeast
TIM23 complex (Chacinska et al., 2005; D’Silva et al., 2008).
Moreover, expression of DNAJC19 failed to restore the viability
of yPam18-deficient yeast cells in recent complementation
experiments (Schusdziarra et al., 2013).
It is therefore conceivable that DNAJC19 has co-opted func-
tions in association with the PHB complex. To examine this pos-
sibility, we employed a biochemical approach in order to
identify binding partners of both DNAJC19 and PAM16. We
generated tetracycline-inducible HEK293T cells expressing
either C-terminally FLAG-tagged DNAJC19 or C-terminally
FLAG-tagged PAM16. DNAJC19FLAGwas efficiently precipitated
frommitochondrial lysates with FLAG antibodies (Figure 3A). We
detected endogenous DNAJC19 in the DNAJC19FLAG eluates,
indicating oligomerization of DNAJC19 (Figure 3A). Similarly,
endogenous DNAJC19 was copurified with PAM16FLAG, sug-
gesting that DNAJC19 and PAM16 interact. However, when
further examining DNAJC19FLAG and PAM16FLAG immunopre-
cipitates, we observed quantitative differences in their respec-tive binding partners. The PHB complex as well as the m-AAA
protease subunit AFG3L2 were precipitated with higher effi-
ciency with DNAJC19FLAG than with PAM16FLAG (Figure 3A),
which is in agreement with the 27-fold enrichment of DNAJC19
compared to a 9-fold enrichment of PAM16 in the CNAP-PHB2
purification (Table 1). We made similar observations when
decreasing the expression level of DNAJC19FLAG to levels
comparable to endogenous DNAJC19 levels (Figure S1B).
Conversely, PAM16FLAG showed a higher affinity for TIM23 and
TIM44, consistent with the predicted function of PAM16 during
mitochondrial protein import (Figures 3A and S1B). We also
observed more efficient binding of subunits of OXPHOS com-
plexes III and V to PAM16 (Figure 3A). Notably, a fraction of these
complexes was found to interact with TIM23 translocases in
yeast (Wiedemann et al., 2007).
To directly assess the assembly of DNAJC19 and PAM16 into
different oligomeric complexes, we analyzed lysates of mito-
chondria that were isolated from either DNAJC19FLAG- or from
PAM16FLAG-expressing cells by blue native gel electrophoresis
(BN-PAGE) (Figure 3B). Both PHB2 and AFG3L2 form large com-
plexes of 0.8–1MDa. Additionally, a fraction of both proteins was
recovered in an even larger assembly, which representsCell Metabolism 20, 158–171, July 1, 2014 ª2014 Elsevier Inc. 161
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Figure 3. DNAJC19 Forms a High-Molecular-Weight Complex with Prohibitins
(A) Immunoprecipitation of FLAG-tagged DNAJC19 and PAM16. Mitochondria were isolated from HEK293T cells expressing DNAJC19FLAG or PAM16FLAG for
2 days (1 mg/ ml tetracycline) and solubilized with digitonin, followed by immunoprecipitation. Input (10%) and eluate (100%) fractions were analyzed by
immunoblotting. Untransfected HEK293T cells were used as control.
(legend continued on next page)
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CL Remodeling Requires the PHB/DNAJC19 Complexsupercomplexes of prohibitins and the m-AAA protease that
we termed PMA (prohibitin/m-AAA protease) complexes.
DNAJC19FLAG comigrated with both PHB2-containing com-
plexes. In agreement with these findings, endogenous DNAJC19
was predominantly found in association with PHB complexes in
control cells (Figure 3B).
To substantiate these findings, we performed native immuno-
precipitation experiments using cells expressing either
DNAJC19FLAG or PAM16FLAG. The native complexes were eluted
with FLAG peptides and analyzed by BN-PAGE (Figure 3C).
Immunoprecipitation of DNAJC19FLAG allowed efficient purifica-
tion of both PHB and PMA complexes, whereas only trace
amounts of TIM23 complexes were detected in the precipitate
(Figure 3C). In striking contrast, TIM23 complexes but only minor
amounts of PHB2 or AFG3L2 complexes were purified with
PAM16FLAG (Figure 3C).
Taken together, these experiments identify DNAJC19 and
PAM16 as part of different high-molecular-weight complexes.
PAM16 mainly interacts with the TIM23 translocase, suggesting
a predominant function during mitochondrial protein import. In
contrast, the vast majority of DNAJC19 assembles with PHB2-
containing complexes.
Assembly of DNAJC19 with PHB Complexes Does Not
Depend on them-AAA Protease
The assembly of DNAJC19 with PMA complexes raises the
question of whether DNAJC19 binds directly to PHB complexes
or to the m-AAA protease. To distinguish between these possi-
bilities, we isolated mitochondria from MEFs lacking either
PHB2 (Merkwirth et al., 2008) or the m-AAA protease subunits
AFG3L1 and AFG3L2. Cre transduction of Phb2fl/flMEFs allowed
efficient depletion of PHB2 and led to the concomitant degrada-
tion of PHB1 (Figure 3D). Interestingly, we observed significantly
reduced steady-state levels of AFG3L1, AFG3L2, and DNAJC19
in these cells, pointing to a functional interdependence of these
proteins (Figure 3D). In contrast, loss of the m-AAA protease
subunits AFG3L1 and AFG3L2 did not affect the accumulation
of PHB1, PHB2, or DNAJC19 (Figure 3D).
BN-PAGE analysis revealed that depletion of PHB2 from
Phb2fl/fl MEFs caused an almost complete loss of assembled
PHB complexes and drastically decreased the fraction of
DNAJC19 present in the high-molecular-weight form (Figure 3E).
Conversely, the absence of AFG3L1 and AFG3L2 did not affect
the formation of PHB complexes nor their assembly with
DNAJC19 (Figure 3E). We therefore conclude that DNAJC19
assembles with PHB complexes independent of the m-AAA
protease. Consistently, PMA complexes accumulated in
DNAJC19FLAG precipitates when compared to free m-AAA pro-
tease complexes (Figure 3C).(B) DNAJC19 comigrates with the PHB complex. Mitochondria isolated from HE
BN-PAGE followed by immunoblotting.
(C) DNAJC19 assembles with prohibitins while PAM16 binds to TIM23 translocas
natively eluted using 3xFLAG peptide. Input (8%) and eluate (100%) fractions we
(D) Steady-state levels of proteins in mitochondria lacking PHB orm-AAA proteas
MEFs transduced with Cre-recombinase when indicated and analyzed by SDS-P
were quantified and are shown relative to mitochondria isolated from untreated
(E) DNAJC19 assembleswith prohibitins in the absence of them-AAA protease. M
lysates were subjected to BN-PAGE and analyzed by immunoblotting.
See also Figure S1.DNAJC19 and Prohibitins Are Functionally Linked
Mutations inDnajc19 that are associated with DCMA lead to loss
of functional protein (Davey et al., 2006; Ojala et al., 2012). We
performed siRNA-mediated knockdown experiments to define
roles of DNAJC19 in mitochondria and in the pathogenesis of
DCMA. Similar to cells lacking PHB2 (Merkwirth et al., 2008),
we observed a significantly decreased cell growth upon deple-
tion of DNAJC19 when compared to control cells (Figure 4A).
Expression of a siRNA-resistant form of DNAJC19FLAG restored
cell growth, confirming the specificity of the siRNA and the func-
tionality of DNAJC19FLAG. Interestingly, DNAJC19 variants car-
rying mutations in the conserved HPD motif within the J-domain
were not able to maintain cell growth upon depletion of endoge-
nous DNAJC19 (Figure 4A). However, the DNAJC19H90Q mutant
(QPD) was still able to interact with prohibitins (Figures 4B and
S2). Thus, cell growth and the function of DNAJC19 depends
on the J-domain of DNAJC19, which is dispensable for prohibitin
binding.
Similar to the loss of PHB2, DNAJC19 depletion led to the loss
of L-OPA1, which is required for mitochondrial fusion and cristae
morphogenesis (Figure 4A) (Anand et al., 2014). Expression of
siRNA-resistant DNAJC19FLAG stabilized L-OPA1, whereas
L-OPA1 did not accumulate in cells expressing functionally inac-
tive DNAJC19FLAG variants (Figure 4A). The metallopeptidase
OMA1 mediates degradation of L-OPA1 in depolarized mito-
chondria (Baker et al., 2014; Ehses et al., 2009; Head et al.,
2009). We therefore downregulated OMA1 by siRNA in
DNAJC19-depleted cells and monitored the accumulation of
L-OPA1 (Figure 4C). Depletion of OMA1 stabilized L-OPA1 in
the absence of DNAJC19 (Figure 4C), demonstrating that the
loss of DNAJC19 leads to activation of OMA1. However, deple-
tion of DNAJC19 did not significantly affect the mitochondrial
membrane potential, suggesting that DNAJC19 affects OMA1
activity in a different manner (Figure 4D).
The loss of L-OPA1 in PHB2-deficient cells is accompanied by
the loss of mitochondrial cristae (Merkwirth et al., 2008). Consis-
tently, we observed a disturbed mitochondrial ultrastructure in
DNAJC19-depleted cells (Figure 4E). Cristae were frequently
lost and appeared vesiculated rather than forming lamellar struc-
tures observed in control cells (Figure 4E). Surprisingly, downre-
gulation of OMA1 in DNAJC19-deficient cells stabilized L-OPA1
but did not restore the mitochondrial ultrastructure (Fig-
ure 4E), indicating that other cellular defects disturb cristae
morphogenesis.
The striking similarities in the phenotypes associated with the
loss of DNAJC19 or PHB2 were further substantiated by gene
expression profiling of DNAJC19- and PHB2-deficient cells.
Heat maps of the top 100 most significantly dysregulated genes
exhibited similar clustering in PHB2- and DNAJC19-depletedK293T cells expressing either DNAJC19FLAG or PAM16FLAG were analyzed by
es. Complexes containing DNAJC19FLAG or PAM16FLAG were precipitated and
re analyzed by BN-PAGE and immunoblotting.
e complexes. Mitochondria were isolated from Phb2fl/fl and Afg3l1//Afg3l2fl/fl
AGE and immunoblotting. Protein levels from three independent experiments
Phb2fl/fl cells. Error bars indicate SD values.
EF cell lines were treatedwith Cre-recombinasewhere indicated. Mitochondrial
Cell Metabolism 20, 158–171, July 1, 2014 ª2014 Elsevier Inc. 163
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Figure 4. DNAJC19 Depletion Affects Cell Growth, OPA1 Processing, and Mitochondrial Cristae Morphogenesis
(A) Loss of functional DNAJC19 reduces cell growth. HEK293T cells tetracycline-inducibly expressing siRNA-resistant DNAJC19FLAG (HPD), DNAJC19FLAG;H90Q
(QPD), or DNAJC19FLAG;H90A;P91A;D92A (AAA) were treated with control siRNA (siNT) or siDNAJC19 for 4 days. The number of cells represents the mean of three
independent experiments. Starting cell number is marked as a dashed line. Relative expression levels were determined by SDS-PAGE and immunoblotting. Error
bars indicate SD values. ***p < 0.001.
(legend continued on next page)
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ure S3). Pathway analyses identified the lipid metabolism, most
prominently cholesterol biosynthesis, to be the most dysregu-
lated function (Figure S3 and Table S1). Interestingly, many
differentially regulated genes are under the control of SREBF1
and SREBF2 (sterol regulatory element-binding transcription
factor), which are required for lipid homeostasis and are pre-
dicted to be inhibited in PHB2- and DNAJC19-depleted cells
(Figure S3).
In view of the phenotypic similarities of cells lacking DNAJC19
or PHB2, it is conceivable that DNAJC19 acting as a molecular
chaperone is required for the assembly of the PHB complex
or its interaction with the m-AAA protease. To examine this
possibility, we analyzed the formation of PHB complexes in
DNAJC19-deficient cells by BN-PAGE. We observed assembly
of both PHB and PMA complexes in mitochondria depleted
of DNAJC19, indicating that DNAJC19 does not serve as
an assembly factor for these complexes (Figure 4F). Thus,
functional deficiencies in the absence of DNAJC19 are not
caused by an impaired assembly and a functional loss of PHB
complexes. Likely, DNAJC19 assembles with prohibitins in
a functional complex, which is inactivated upon loss of one
component.
The Loss of DNAJC19 or TAZ Causes Similar Alterations
in CL Acyl Chains
The related clinical presentations of DCMA and BTHS patients
prompted us to examine the lipid composition of mitochondrial
membranes lacking DNAJC19. We depleted DNAJC19 and, for
comparison, TAZ in HEK293T cells, isolated mitochondria, and
determined the phospholipid composition of the membranes
by quantitative MS (Figure 5A). In agreement with previous find-
ings (Gu et al., 2004; Houtkooper et al., 2009), loss of TAZ led to
decreased CL levels (Figure 5A) and to accumulation of MLCL,
the substrate of TAZ (Figure 5B). Depletion of DNAJC19 did
not affect CL levels in mitochondrial membranes, nor did
MLCL accumulate (Figures 5A and 5B). However, the acyl chain
composition of CLwas altered in a strikingly similarmanner in the
absence of DNAJC19 or of TAZ. We observed an overall ten-
dency toward longer and less saturated acyl chains in DNAJC19-
or TAZ-depleted cells (Figures 5C and 5D), as is apparent from a
significant increase in the relative level of CL species with 5–7
double bonds. Notably, we observed similar alterations in the
acylation of CL in cells expressing the DNAJC19H90Q mutant
(Figures S4B–S4D). As described previously for TAZ-deficient
cells (Schlame et al., 2003), acylation of other phospholipids,
namely PE, phosphatidyl serine (PS), and phosphatidyl inositol(B) Binding of DNAJC19 to prohibitins does not depend on the integrity of the J-do
and expressing DNAJC19FLAG (HPD) or DNAJC19FLAG;H90Q (QPD) followed by im
immunoblotting. Untransfected HEK293T cells were used as a control (Ctrl).
(C) OMA1-mediated degradation of L-OPA1 in DNAJC19-deficient cells. The acc
after 4 days of depletion of PHB2, DNAJC19, and OMA1. The levels of MFN2 re
(D) Maintenance of mitochondrial membrane potential upon DNAJC19 depletion
were analyzed by flow cytometry. Ratio of red to green fluorescence from four inde
(E) Defective cristae morphogenesis in DNAJC19-depleted cells. Transmission el
(siNT) siRNA. Scale bar: 0.2 mm.
(F) Assembly of PHB and PMA complexes in DNAJC19-deficient cells. Mitochon
BN-PAGE and immunoblotting using the indicated antibodies.
See also Figure S2.(PI), was also affected in the absence of functional DNAJC19
(Figures S5C–S5F).
Taken together, these experiments demonstrate that loss of
TAZ or DNAJC19 leads to strikingly similar alterations in the
acyl chain composition of CL and other mitochondrial phospho-
lipids, pointing to related pathogenic mechanisms in DCMA and
BTHS. Interestingly, we observed similar alterations in CL acyla-
tion upon depletion of DNAJC19 inOma1/HEK293T cells (Fig-
ures 5E and 5F), where L-OPA1 was stabilized. Moreover, loss of
TAZ did not destabilize L-OPA1 (Figure S4A), although cristae
morphogenesis is impaired in TAZ-deficient BTHS cells (Acehan
et al., 2007). It is therefore conceivable that the altered acylation
of CL and other phospholipids causes the disruption of cristae
structure in these cells.
CL Accumulation and Composition Depends on PHB
Complexes
Our findings raised the possibility that PHB complexes binding
DNAJC19 affect the phospholipid composition of mitochondrial
membranes in a similar manner. We therefore depleted PHB2 in
HEK293T cells and analyzed the phospholipid composition of
mitochondrial membranes by MS. Similar to TAZ-deficient cells,
CL was present at significantly reduced levels in mitochondria
lacking PHB2 (Figure 6A), while MLCL slightly accumulated (Fig-
ures 6D and 6E). We observed an increase in CL species with
longer and less saturated acyl chains (Figures 6B and 6C), as
found in DNAJC19- or TAZ-depleted cells.
To further define at which step the PHB/DNAJC19 complex
affects CL biogenesis, we examined whether the formation of
MLCL in the absence of TAZ depends on DNAJC19 and PHB2
(Figure 6E). MLCL accumulated at similar levels regardless of
the presence or absence of DNAJC19 or PHB2 (Figure 6E).
Moreover, depletion of TAZ in cells lacking DNAJC19 or PHB2
did not lead to further alterations in the acylation of CL and other
phospholipids (Figure S5). PHB/DNAJC19 complexes thus
appear to affect the formation of mature CL from MLCL and
may directly regulate the acylation of MLCL by TAZ.
DISCUSSION
We have determined the interactome of mitochondrial PHB
complexes and identified DNAJC19 as an interactor of these
scaffold proteins. We observed alterations in the acyl chain
composition of CL in the absence of DNAJC19 or PHB2 that
are strikingly similar to deficiencies observed in TAZ-deficient
cells. These findings therefore provide insight into the
pathogenesis of DCMA and explain similarities in the clinicalmain. Mitochondria were isolated from cells depleted of endogenous DNAJC19
munoprecipitation. Input (10%) and eluate (100%) fractions were analyzed by
umulation of OPA1 forms was determined by SDS-PAGE and immunoblotting
main unaffected. b-actin was used as loading control.
. HEK293T cells were treated with JC1 4 days after downregulation. Samples
pendent experiments was normalized to control. Error bars indicate SD values.
ectron microscopy of HEK293T cells treated with DNAJC19, OMA1, or control
dria were isolated from HEK293T cells depleted of DNAJC19 and analyzed by
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Figure 6. PHB Complexes Ensure the Accu-
mulation and Acylation of Mature CL
(A) Decreased CL levels in PHB2-depleted mito-
chondria. The phospholipidome of mitochondria
purified fromPHB2-deficient cells was determined
by quantitative MS. Error bars indicate SD values.
n = 3; **p < 0.01.
(B and C) Accumulation of CL species with longer
(B) and more unsaturated (C) acyl chains in PHB2-
deficient cells. Data were analyzed as in Figures
5C and 5D. Error bars indicate SD values. n = 3;
*p < 0.05; **p < 0.01; ***p < 0.001.
(D) Accumulation of MLCL in PHB2-deficient cells.
Survey scans show theMS profile of MLCL andCL
in PHB2-deficient and control cells. IS, internal
standard.
(E) The formation of MLCL in TAZ-deficient cells
does not depend on the PHB/DNAJC19 complex.
Mitochondria were isolated from HEK293T cells
treated with the indicated siRNAs and phospho-
lipids were quantified by MS. Error bars indicate
SD values. n = 3; *p < 0.05; **p < 0.01.
See also Figure S5.
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similar alterations in the lipid composition of mitochondrial
membranes.
Our biochemical analysis demonstrates that DNAJC19 asso-
ciates predominantly with PHB complexes and not with TIM23
translocases, as had been suggested by the sequence similar-
ities of DNAJC19 with yPam18 (Davey et al., 2006). This is in
contrast to PAM16, which assembles with TIM23 complexes
and therefore is likely involved in protein import into mitochon-
dria. Although DNAJC19 binds to PAM16 and may contribute
to the membrane translocation of mitochondrial preproteins,
this appears not to be its master function. Whereas yPam18 is
essential for cell survival in yeast, the loss of DNAJC19 in
DCMA patients does not affect the accumulation of OXPHOSFigure 5. Altered CL Acylation in Mitochondria Lacking DNAJC19
(A) Phospholipidome of DNAJC19-deficient mitochondria. MS analysis of mitochondrial membranes isolate
(siNT), DNAJC19-, or TAZ-specific siRNA. The error bars indicate SD values. n = 3; **p < 0.01.
(B) MLCL does not accumulate upon loss of DNAJC19. Mass spectrometric profile of CL. A survey scan for pr
MLCL and CL. IS, internal standard.
(C–F) Accumulation of CL species with longer (C, E) and more unsaturated (D, F) acyl chains in DNAJC19- or
HEK293T cells depleted of DNAJC19. Quantity of CL species carrying acyl chains with represented number
and then represented as a proportion in total amount of CL. Error bars indicate SD values. n = 3; *p < 0.05;
See also Figure S4.
Cell Metabolism 20, 158components or other mitochondrial pro-
teins (Ojala et al., 2012). Moreover,
expression of DNAJC19 fails to allow
growth of Pam18-deficient yeast cells,
which was restored upon expression of
DNAJC15 (Schusdziarra et al., 2013),
pointing to other functions of DNAJC19
in mitochondria. We observed similar
functional deficiencies in the absence of
DNAJC19 or PHB2, including impaired
cell growth, a disturbed mitochondrial ul-
trastructure, and similar transcriptionalresponses, suggesting that the PHB/DNAJC19 complex repre-
sents the functional active structure.
How does DNAJC19 affect the functional integrity of mito-
chondria? Similar to PHB2, the loss of DNAJC19 triggers
degradation of L-OPA1, which is required for mitochondrial
fusion and the maintenance of cristae structure (Anand et al.,
2014; Ishihara et al., 2006). However, stabilization of L-OPA1
upon downregulation of OMA1 did not restore normal mito-
chondrial cristae, suggesting that other deficiencies disturb
the mitochondrial ultrastructure in the absence of DNAJC19.
We observed profound alterations in the acyl chain composi-
tion of CL in these cells: longer and more unsaturated fatty
acids accumulated, whereas shorter and more saturated fatty
acids were decreased. These alterations are reminiscent ofd from HEK293T cells treated with control siRNA
ecursors of m/z 152.9 was performed to determine
TAZ-deficient HEK293T cells (C, D) and Oma1/
of total carbons or of double bonds were summed
**p < 0.01; ***p < 0.001.
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homeostasis is of pathogenic relevance in DCMA as it is in
BTHS. Interestingly, in contrast to cells lacking TAZ, MLCL
did not accumulate in DNAJC19-deficient cells, nor was CL
decreased. It thus appears that differences in acyl chains of
CL and other phospholipids impair the functional integrity of
mitochondrial membranes in DCMA. Consistently, we did not
observe loss of L-OPA1 in TAZ-deficient cells (Figure S4A),
although a disturbed mitochondrial ultrastructure was reported
for BTHS lymphoblasts (Acehan et al., 2007), indicating that
mitochondrial cristae alterations are caused by disturbed
phospholipid homeostasis independently of L-OPA1 in both
DCMA and BTHS.
Three different enzymes have been linked to CL remodeling
and might therefore be affected by the loss of the PHB/
DNAJC19 complex. A low MLCL acyltransferase activity has
been reported for MLCLAT-1, which is identical to the
C-terminal domain of the a subunit of the trifunctional protein
(TFPa) (Taylor and Hatch, 2009; Taylor et al., 2012). However,
we did not observe significant alterations in the accumulation
of CL and MLCL nor in CL acyl chains upon depletion of TFPa
(Figure S6), similar to previous findings in Drosophila mela-
nogaster (Schlame et al., 2012b). Thus, DNAJC19 likely does
not modulate MLCL acylation by affecting the activity of TFPa.
Similarly, the activity of the acyl-CoA:lyso-CL acyltransferase
(ALCAT1), which is present in mitochondria-associated ER
membranes and contributes to CL acylation (Li et al., 2010),
seems not to be affected by the loss of DNAJC19 or PHB2.
Decreased levels of CL, altered CL acyl chains, and mitochon-
drial fragmentation have been observed upon overexpression
of ALCAT1 (Li et al., 2010, 2012). However, in view of the local-
ization of ALCAT1, we consider a direct effect of PHB/DNAJC19
complexes on its activity unlikely. Moreover, the altered
acylation of CL in ALCAT1-deficient cells was explained by a
decreased expression of MFN2 in these cells that alters phos-
pholipid exchange between ER and mitochondria. However,
we did not observe altered steady-state levels of MFN2 in
DNAJC19- or PHB2-deficient cells (Figure 4C), suggesting that
ALCAT1 activity remained unaffected in these cells.
We propose that DNAJC19 in complex with prohibitins regu-
lates CL remodeling by affecting the activity of TAZ within
mitochondria. The loss of DNAJC19 or PHB2 did not impair
the accumulation of MLCL in the absence of TAZ, but affected
the accumulation of mature CL in the presence of the acyltrans-
ferase. We did not detect a physical interaction of TAZ with
DNAJC19 or PHB complexes. Rather, PHB/DNAJC19 com-
plexes may define functional membrane domains with charac-
teristic membrane properties, e.g., with a defined CL/MLCL ratio
or membrane curvature, facilitating MLCL acylation by TAZ. In
agreement with such a scenario, TAZ reacts only with a small
proportion of CL in the membrane that might exhibit positive
or negative curvature or be present in a nonbilayer state
(Schlame et al., 2012a). CL remodeling is thought to minimize
the packing energy of lipids, facilitating dynamic changes in
the conformation of mitochondrial membranes (Schlame,
2013). Accordingly, alterations in the acyl chain composition of
membrane lipids are likely to interfere with membrane rear-
rangements and may disturb the morphology of cristae in
DNAJC19-deficient mitochondria. Furthermore, the defined lipid168 Cell Metabolism 20, 158–171, July 1, 2014 ª2014 Elsevier Inc.environment within a PHB membrane domain may also ensure
the specificity of transacylation by TAZ, which was observed
to be nonspecific in vitro (Malhotra et al., 2009) and to be
confined to the specific lipid environment in vivo (Schlame
et al., 2012a). The loss of PHB/DNAJC19 complexes would
enable TAZ to transfer acyl chains to phospholipids other than
MLCL, explaining the presence of different altered acyl chains
in various mitochondrial phospholipids in the absence of PHB/
DNAJC19 complexes.
Our studies reveal an unexpected function of PHB membrane
scaffolds for the CL metabolism. The alterations in CL acylation,
the moderately decreased CL levels, and similar transcriptional
responses affecting cholesterol synthesis in PHB2-deficient
cells are reminiscent of DNAJC19- and TAZ-depleted cells and
make Phb1 and Phb2 candidate genes mutated in cardiomyop-
athies. Moreover, the newly identified binding partners of PHB
complexes link their function to the assembly of OXPHOS com-
plexes and protein translocases, multiprotein complexes whose
assembly and stability is known to depend on CL. The PHB inter-
actome may therefore pave the way for a deeper understanding
of the mechanisms determining the supramolecular organization
in the IMMand its role for mitochondrial activity, cell survival, and
lifespan.
EXPERIMENTAL PROCEDURES
Generating Stable Cell Lines
For the generation of stable MEF cell line, SV40-transformed Phb2fl/fl MEFs
(Merkwirth et al., 2008) were transfected via electroporation with pCAGs-
STOP-IRES-EGFP plasmid containing murine Phb2 cDNA with CNAP-tag at
the 50 end. One day after transfection, cells were selected with 300 mg/ml
G418 for 10 days. Single G418-resistant MEF clones were isolated and
expanded for further analysis. Cre protein transduction was performed as
described previously (Merkwirth et al., 2008). Cells expressing CNAP-PHB2
(Phb2/::CNAP-Phb2) were isolated with FACSVantage SE (Becton
Dickinson) based on GFP expression upon Cre-mediated recombination in
these cells.
HEK293T cells were transfected with pcDNA5-FRT-TO (with gene of
interest) and pOG44 to generate stable tetracycline-inducible cell lines using
GeneJuice (Novagen) as transfection reagent. Selection was started 2 days
later using hygromycin (100 mg/ml). Single clones were isolated after 2 weeks’
selection.
Determination of the PHB Interactome Using CNAP-PHB2
Purification of CNAP-PHB2was performed according to Claypool et al. (2008).
Briefly, mitochondria were lysed in solubilization buffer (20 mM HEPES/KOH
[pH 7.4], 20 mM imidazole/HCl [pH 7.4], 100 mM NaCl, 10% glycerol, 1 mM
CaCl2, Protease Inhibitor Cocktail Mix [Roche], 8 g digitonin/g protein) for
30 min prior to centrifugation for 20 min at 20,0003 g. The supernatant was
transferred to pre-equilibrated Ni-NTA Sepharose (Ni2+ Sepharose High Per-
formance, GE). After 1.5 hr beads were washedwith increasing concentrations
of imidazole (20 mM, 50 mM, 100 mM, 200 mM) prior to elution with 500 mM
imidazole. Samples were either analyzed by tandem mass spectrometry or
TCA precipitated prior to SDS-PAGE and immunoblotting.
Coimmunoprecipitation of FLAG-Tagged DNAJC19 and PAM16
Coimmunoprecipitation via FLAG-tag was performed using EZview Red Anti-
FLAGM2 Affinity Gel (Sigma). Mitochondria were isolated from HEK293T cells
expressing FLAG-tagged protein and lysed (150 mM NaCl, 50 mM Tris/HCl
[pH 7.4], 2 mM EDTA, Protease Inhibitor Cocktail Mix [Roche], 4 g digitonin/
g protein) prior to centrifugation for 10 min at 10,0003 g at 4C. Digitonin con-
centration of cleared supernatants was diluted to 0.4% (final concentration)
prior to incubation with anti-FLAG M2 beads for 2 hr. Finally, beads were
washed three times (150 mM NaCl, 50 mM Tris/HCl [pH 7.4], 2 mM EDTA,
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eluted either via pH shift with 200 mM NH3 or natively with 3x FLAG peptide.
Samples were further analyzed either by BN-PAGE or by SDS-PAGE followed
by immunoblotting.
Blue Native PAGE
BN-PAGE was performed as described previously with some modifications
(Wittig et al., 2006). Briefly, mitochondria (100 mg) were lysed in solubilization
buffer (50 mM NaCl, 5 mM 6-aminohexanoic acid, 50 mM imidazole/HCl
[pH 7], 10% glycerol, 50 mM KPi-buffer [pH 7.4]) containing 8 g digitonin/g
protein. Lysates or eluates from coimmunoprecipitation experiments were
centrifuged, supplemented with 0.1% CBB, and separated by 3%–13%
BN-PAGE.
Mitochondria Isolation and Purification
Cells were washed in PBS and resuspended in homogenization buffer
(220 mM mannitol, 70 mM sucrose, 20 mM HEPES/KOH [pH 7.4], 1 mM
EDTA) containing 0.2% BSA and 1 mM PMSF. Cell suspension was homoge-
nized with a rotating Teflon potter (Potter S, Braun) at 900 rpm followed by
differential centrifugation.
For lipidome analysis, mitochondria were purified over a 40%-26%-12%
percoll gradient (45 min at 56,7003 g). Protein layers were isolated, washed
with homogenization buffer, and analyzed onmitochondrial purity and integrity
by immunoblotting.
Mass Spectrometric Lipid Analysis
Mass spectrometric analysis of mitochondrial phospholipids was performed
essentially as previously described (Connerth et al., 2012), with some optimi-
zation for MLCL. Lipids were extracted from percoll gradient-purified mito-
chondria (100 mg) in the presence of internal standards that were obtained
from Avanti Polar Lipids: PC 17:0-14:1, PE 17:0-14:1, PI 17:0-14:1, PS 17:0-
14:1, PG 17:0-14:1, PA 17:0-14:1, CDP-DAG 17:0-18:1, CL 14:0-14:0-14:0-
14:0, and MLCL (from heart). Extraction was performed according to Bligh
and Dyer with modifications. Briefly, 100 ml of 1 mg/ml mitochondria and stan-
dards are mixed with 2 ml of chloroform/methanol/25% HCl (40:80:0.6 [v/v]).
After vortexing for 30 s, H2O (0.4 ml) was added followed by vortexing. After
the addition of 0.5 ml chloroform and 0.5 ml H2O, the sample was mixed again
and phase separation was induced by centrifugation (8003 g, 2 min). The
lower chloroform phase was transferred to a second vial, and the remaining
phases were washed after the addition of 0.5 ml chloroform and 0.8 ml H2O.
The washed chloroform phase of the second vial was transferred to a third
vial, and the chloroform phase of the initial vial was combinedwith the aqueous
phase of the second vial followed by re-extraction. After phase separation, the
chloroform phases were combined and evaporated by a gentle stream of
argon at 37C. If necessary, wash step by water was omitted to increase the
recovery of MLCL, and HCl was removed from the extraction solution to sup-
press the acid-induced deacylation of CL to MLCL during the analysis. Lipids
were dissolved in 5 mM ammonium acetate and 0.05% piperidine in methanol
and analyzed on a 4000 QTrap triple quadrupole mass spectrometer (Applied
Biosystems, Darmstadt, Germany) equipped with a Turbo V electrospray ion
source as previously described. PC, PE, PI, PS, PG, and PA species were
analyzed as described (Connerth et al., 2012). CL and MLCL species were
identified in negative ion mode by scanning for precursors of m/z 152.9 and
quantified by MRM as singly charged ions [M-H] at a CE of 60 eV with
100 ms dwell time. Scanned m/z and corresponding CL/MLCL species are
as follows: 1239.9, CL 56:0 (internal standard); 1343.8, CL 64:4; 1345.9, CL
64.3; 1347.9, CL 64:3; 1347.9, CL 64:2; 1349.9, CL 64:1; 1369.9, CL 66:5;
1371.9, CL 66:4, 1373.9, CL 66:3, 1376.0, CL 66:2; 1398.0, CL 68:5; 1400.0,
CL 68:4; 1402.0, CL 68:3; 1404.0, CL 68:2; 1422.0, CL 70:7; 1424.0, CL
70:6; 1426.0, CL 70:5; 1428.2, CL 70:4; 1430.0, CL 70:3; 1448.0, CL 72:8;
1450.0, CL 72:7; 1452.0, CL 72:6; 1454.0, CL 72:5; 1456.0, CL 72:4; 1458.0,
CL 72:3; 1460.0, CL 72:2; 1462.0, CL 72:1; 1464.0, CL 72:0; 1109.9, MLCL
48:2; 1111.8, MLCL 48:1; 1134.0, MLCL 50:4; 1135.9, MLCL 50:3; 1137.9,
MLCL 50:2; 1139.9, MLCL 50:1; 1161.9, MLCL 52:4; 1163.9, MLCL 52:3;
1166.0, MLCL 52:2; 1167.9, MLCL 52:1; 1186.0, MLCL 54:6; 1187.9, MLCL
54:5; 1190.0, MLCL 54:4; 1192.0, MLCL 54:3; 1193.9, MLCL 54:2. Mass
spectra were processed by the LipidView Software Version 2.0 (AB Sciex,
Darmstadt, Germany) for identification and quantification of lipids. Lipidamounts (pmol) were corrected for response differences between internal
standards and endogenous lipids. For the analysis of length and saturation
profile of the acyl chains in a phospholipid, amounts of phospholipid species
carrying acyl chains with the same number of total carbons or of double bonds
were summed and then represented as a proportion in total amount of the
phospholipid.
Statistical Evaluation
Means are presented with standard deviations (SD). Student’s t test was
performed to examine the significance of observed differences.
Miscellaneous
Further experimental procedures can be found in the Supplemental
Information.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2014.04.016.
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